Clicks achieving double digit earnings growth

The Clicks Group has managed to produce another strong set of results

For the year ending 31 August 2016 The Clicks Group has managed to produce another strong set of results, despite the currently weak consumer spending environment.

Some of the salient features of the results are as follows:

  • Group Turnover +9.5%
  • Operating profit +12.6%
  • Headline earnings per share (HEPS) +15.8%
  • Total Dividend +15.7%
  • Return on equity (ROE) 49.2%

The company has continued to produce an exceptionally high ROE, operating on good margins and achieving double digit earnings growth in the low end of the current business cycle. The retail segment of the business, which remains the most meaningful contributor to profit (more than 80% thereof), has seen profit before tax (PBT) grow 13.47%. The distribution segment grew PBT by 6.7%.

The results build upon what has been consistent year on year earnings growth for the company, However, trading on a price to earnings ratio not far off of 30 times does suggest the Clicks Group to still be a little on the expensive side at the moment relative to the growth  achieved.

Recent news that its unlisted competitor in the food and drug retail space, Dis-Chem, is looking to list on the Johannesburg Stock Exchange, in lieu of aiding its own expansion efforts could pose future headwind for Clicks. In the most recent financial year Dis-Chem achieved R15.5bn in revenue which compares to R25.5bn of revenue in 2016 from The Clicks Group. The Dis-Chem pharmacy chain currently has 101 stores in South Africa and another two partner stores in Namibia. The new public listing would look to help fund future growth in which Dis-Chem is looking to double the number of stores in operation over the next five to eight years. The Clicks store footprint currently sits at 511.

While the Clicks Group continues to grow revenue and offers a fair dividend yield of just over 2%, the current pricing of the share does seem a bit over extended at the moment. The uncertain future impact of the competitive landscape combined with a financially pressured consumer also provides a further caution for the share. But one cannot ignore the stellar results and massive ROE. It is with these considerations that the company is perhaps best considered a hold at present. We expect to see continued range bound trading activity as we wait for earnings to catch up with the current pricing of the share.   In the short to medium term the range considered looks to be between levels 11880 and 13020. 

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Find articles by analysts

This information has been prepared by IG, a trading name of IG Markets Limited and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. International accounts are offered by IG Markets Limited in the UK (FCA Number 195355), a juristic representative of IG Markets South Africa Limited (FSP No 41393). South African residents are required to obtain the necessary tax clearance certificates in line with their foreign investment allowance and may not use credit or debit cards to fund their international account.